Robert F. Kennedy Jr.’s appointment as Secretary of Health and Human Services marked one of the most dramatic shifts in American public health leadership in modern history. RFK Jr., a figure long associated with vaccine skepticism and environmental activism, now controls the agencies responsible for protecting the nation’s health — the CDC, FDA, and NIH. His policy changes are reshaping everything from childhood vaccine recommendations to mental health funding to drug approval processes, all while measles outbreaks spread across the United States. Whether these changes represent long-overdue reform or a dangerous dismantling of public health infrastructure depends on who you ask — and what the evidence actually shows.
RFK Jr.’s Vaccine Policy: What’s Actually Changing at the CDC
Perhaps the most consequential aspect of Kennedy’s tenure involves the CDC’s longstanding position on vaccine safety. From his first days in office, Kennedy made clear that addressing what he termed the “childhood chronic disease epidemic” was a primary mission — language that closely mirrors his decades of advocacy through Children’s Health Defense, the organization he founded and led before his appointment.
The structural changes are significant. In June 2025, HHS announced the reconstitution of the Advisory Committee on Immunization Practices (ACIP), the expert body whose recommendations shape national vaccine schedules for over 70 million American children. ACIP’s guidance directly influences which vaccines are required for school enrollment, covered by insurance, and recommended by pediatricians. The stated goal of the reconstitution was to “Restore Public Trust in Vaccines,” but critics argue the real purpose was to install members more sympathetic to Kennedy’s skepticism about vaccine safety.
The appointment of new ACIP members in September 2025 was widely interpreted as introducing voices aligned with Kennedy’s positions. This represents a structural shift in who advises on vaccine policy — and in public health, the composition of advisory bodies shapes recommendations, recommendations shape policy, and policy shapes behavior. You don’t need to officially reverse a scientific position if you appoint advisors who will gradually soften it.
While no publicly released directive explicitly orders the CDC to reverse its position that vaccines don’t cause autism, the direction of institutional change is unmistakable. Internal communications reported by multiple news outlets suggest a chilling effect on CDC scientists, with researchers describing pressure to soften language about vaccine safety and avoid publicly contradicting the Secretary’s stated priorities.
Do Vaccines Cause Autism? What the Science Actually Shows
The scientific consensus on vaccines and autism is unequivocal: vaccines do not cause autism. This isn’t based on a handful of studies — it’s the product of some of the largest and most rigorous epidemiological research ever conducted.
Key studies include:
-
The Danish cohort study (2019): Followed 657,461 children born between 1999 and 2010. Found no increased risk of autism in children who received the MMR vaccine compared to those who didn’t, even among children with autism risk factors (sibling history of autism, preterm birth). Published in Annals of Internal Medicine.
-
The Cochrane Review (2012, updated 2020): Analyzed data from 14.7 million children across multiple countries and found no link between the MMR vaccine and autism, encephalitis, or other serious adverse events. The Cochrane Collaboration is widely considered the gold standard for medical evidence synthesis.
-
The meta-analysis by Taylor et al. (2014): Combined data from studies involving 1.27 million children and found no relationship between vaccination and autism. Published in Vaccine.
-
The thimerosal studies: After concerns about the mercury-based preservative thimerosal (used in some vaccine formulations), multiple studies examined the relationship — including a 2003 Danish study of over 467,000 children. No association was found. Thimerosal has been removed from virtually all childhood vaccines in the U.S. since 2001 as a precautionary measure, and autism rates continued to increase afterward — inconsistent with thimerosal being a cause.
The origin of the vaccine-autism myth traces to Andrew Wakefield’s 1998 paper in The Lancet, which claimed a link between the MMR vaccine and autism in 12 children. Subsequent investigation by journalist Brian Deer revealed that Wakefield had undisclosed financial conflicts of interest (he had been paid over £400,000 by lawyers seeking to sue vaccine manufacturers), had manipulated data, and had subjected children to unnecessary invasive procedures without ethical approval. The paper was retracted, and Wakefield lost his medical license.
Despite this, the myth persists — largely because autism diagnoses typically occur around the same age that certain vaccines are administered (12-18 months), creating a temporal coincidence that feels causal to parents but isn’t. The expansion of diagnostic criteria for autism spectrum disorder also increased prevalence rates, coinciding with broader vaccine schedules and reinforcing the perceived connection.
This doesn’t mean vaccines carry zero risk. Like all medical interventions, they can cause adverse reactions — soreness at the injection site, mild fever, and in rare cases (roughly 1 in a million), severe allergic reactions. The Vaccine Adverse Event Reporting System (VAERS) and the National Vaccine Injury Compensation Program exist specifically to monitor and address these rare events. The relevant question is always risk-benefit ratio, and for childhood vaccines, the evidence overwhelmingly favors vaccination.
Understanding how our immune system builds memory through exposure provides important context for why vaccines work and why disrupting vaccination schedules has consequences.
The Measles Crisis: A Real-Time Consequence
Kennedy’s policy shifts are unfolding against a backdrop of rising measles cases that provide a real-time illustration of what happens when vaccination rates decline.
Measles was declared eliminated from the United States in 2000 — meaning sustained domestic transmission had been interrupted. That achievement required maintaining vaccination rates above 95%, the threshold for herd immunity against this highly contagious virus. Measles is extraordinarily transmissible: an infected person in a room can transmit the virus to 90% of unvaccinated individuals present, even after leaving the room, because the virus remains airborne for up to two hours.
By 2025-2026, vaccination rates in some communities had declined below the herd immunity threshold, and measles outbreaks followed predictably. The CDC reported hundreds of cases across multiple states, with hospitalization rates consistent with pre-vaccine-era expectations — approximately 1 in 4 cases requiring hospitalization.
Measles is not a benign childhood illness. Before the vaccine was introduced in 1963:
- 400-500 Americans died from measles annually
- 48,000 were hospitalized per year
- 1,000 developed encephalitis (brain swelling) annually
- Pneumonia occurred in approximately 1 in 20 cases
- Subacute sclerosing panencephalitis (SSPE) — a fatal degenerative brain disease — could appear 7-10 years after initial infection, particularly in children infected before age 2
The MMR vaccine reduced measles deaths by 99% in the United States. Globally, measles vaccination prevented an estimated 56 million deaths between 2000 and 2021, according to WHO data. The return of endemic measles transmission in the U.S. would represent one of the most significant public health regressions in modern history.
The signal effect of having the nation’s top health official maintaining a decades-long public record of vaccine skepticism cannot be overstated. When parents who are uncertain about vaccinating their children see the Secretary of HHS questioning vaccine safety, it validates hesitancy regardless of what official policy technically says.
Mental Health and Substance Abuse Funding Cuts: A Hidden Crisis
Kennedy’s reshaping of HHS extends beyond vaccines into mental health and substance abuse treatment — areas facing their own crises that receive far less public attention.
Reports indicate significant cuts to Substance Abuse and Mental Health Services Administration (SAMHSA) grants — funding that supports treatment programs, crisis intervention services, community mental health centers, and the 988 Suicide & Crisis Lifeline across the country. These grants don’t make headlines, but they form the backbone of America’s behavioral health infrastructure.
The timing is devastating. The United States faces overlapping behavioral health emergencies:
-
Overdose deaths reached approximately 107,000 in 2023, driven primarily by synthetic opioids (fentanyl and its analogs). While the number showed early signs of slight decline in 2024, it remains at historically catastrophic levels — more Americans die from overdoses annually than died in the entire Vietnam War.
-
Youth mental health has deteriorated sharply. The CDC’s Youth Risk Behavior Survey found that in 2021, 42% of high school students reported persistent feelings of sadness or hopelessness, 22% seriously considered suicide, and 10% attempted suicide. The Surgeon General declared a youth mental health crisis in 2021.
-
Suicide rates have increased by 35% since 2000. Suicide is the second leading cause of death for Americans aged 10-34. Rural communities, veterans, and LGBTQ+ youth face particularly elevated rates.
-
Treatment access was already insufficient before cuts. According to SAMHSA, only 47% of adults with mental illness received treatment in 2022, and the shortage of mental health professionals — particularly in rural areas — means that even people seeking help often face months-long waits.
Reducing funding for these programs means fewer treatment slots, fewer crisis counselors, fewer community resources for people in acute distress. The effects won’t appear in headlines immediately, but they’ll manifest in emergency rooms, jails, homeless encampments, and obituaries. Our episode on the algorithm predicting pandemics highlighted how early warning systems prevent crises — and these mental health programs serve a similar early-intervention function.
FDA Regulatory Changes Under RFK Jr.
Kennedy’s influence on the FDA represents another significant policy shift with far-reaching consequences for drug safety, food regulation, and public health.
The general direction is clear: a more skeptical posture toward pharmaceutical industry practices, expanded interest in alternative and integrative approaches, and a reconsideration of regulatory frameworks that Kennedy has long criticized as captured by industry interests.
Some instincts have legitimate foundations:
-
The pharmaceutical revolving door is real. Former FDA commissioners have gone on to serve on pharmaceutical company boards with alarming regularity. Scott Gottlieb joined Pfizer’s board. Stephen Hahn joined Flagship Pioneering (which created Moderna). The pattern creates at minimum the appearance of regulatory capture.
-
Drug pricing transparency — understanding why Americans pay dramatically more for the same medications than citizens of other developed nations — is a bipartisan concern that regulatory reform could address.
-
Food additive review — reassessing chemicals approved decades ago under different safety standards — has support from consumer advocates, nutritional scientists, and pediatric health organizations. The FDA’s “Generally Recognized as Safe” (GRAS) process has been criticized for allowing manufacturers to self-certify ingredient safety without independent review.
Where the risk lies:
The distinction between skepticism of pharmaceutical companies (healthy) and skepticism of pharmaceutical science (dangerous) is critical and easily blurred. The clinical trial process — Phase I safety studies, Phase II dose-finding, Phase III randomized controlled efficacy trials, Phase IV post-market surveillance — represents one of the most rigorous evidence-generation systems humans have ever created. Weakening these standards in the name of “medical freedom” or “alternative approaches” could allow ineffective or dangerous treatments to reach patients.
Kennedy’s historical promotion of alternative health approaches — some evidence-based, others not — raises questions about whether FDA standards for efficacy demonstration will be maintained or relaxed. The consequences of getting this wrong are measured in lives.
The Steelman Case: What RFK Jr.’s Supporters Get Right
Dismissing all of Kennedy’s positions as “anti-science” is intellectually lazy and strategically counterproductive. Several of his concerns have legitimate foundations:
The childhood chronic disease burden is real and unexplained. Rates of childhood obesity, asthma, food allergies, ADHD, and autism spectrum disorder have all increased significantly over recent decades. While improved diagnosis accounts for some of the increase, it doesn’t explain all of it. Identifying environmental, dietary, and other contributing factors — including honest evaluation of pharmaceutical exposures — is a legitimate scientific priority.
Pharmaceutical industry influence on regulation is documented. Industry funding of the FDA through user fees (PDUFA), the revolving door between regulatory positions and industry boards, and pharmaceutical company funding of the academic research that informs regulatory decisions all represent real structural problems.
Transparency in public health communication needs improvement. The erosion of public trust in health institutions — accelerated by inconsistent messaging during the COVID-19 pandemic — is a real problem that won’t be solved by repeating “trust the science” louder. Rebuilding trust requires genuine transparency, acknowledgment of uncertainty, and addressing legitimate concerns rather than dismissing them.
Food system reform is overdue. The Standard American Diet’s contribution to chronic disease is well-established, and the FDA’s regulatory approach to food additives, ultra-processed foods, and agricultural chemicals deserves rigorous review.
The question isn’t whether these concerns are valid — many are. The question is whether the specific policy responses being implemented will address them effectively, or whether they’ll create new problems more serious than the ones they’re trying to solve. Undermining evidence-based vaccination programs to address theoretical vaccine concerns, while measles outbreaks actively spread, represents a specific trade-off that deserves the most rigorous scrutiny.
Internal Resistance and Political Dynamics
Reports suggest that even within Trump’s inner circle, there are efforts to moderate Kennedy’s more dramatic policy ambitions. This internal tension reflects the reality that while Kennedy’s appointment energized a specific constituency, the consequences of aggressive public health policy changes create political risks.
Public health infrastructure is slow to build and fast to dismantle. Vaccination programs, disease surveillance systems, mental health networks, drug safety monitoring, and epidemic response capabilities represent decades of institutional development and billions of dollars of investment. Rapid changes to these systems — even changes motivated by genuine concerns — can create vulnerabilities that take years to manifest and decades to repair.
The political calculus is complex. Kennedy’s base is passionate but represents a minority view on most vaccine-related issues — polls consistently show that 70-80% of Americans support childhood vaccination requirements. If measles outbreaks worsen, mental health crises deepen, or drug safety problems emerge due to regulatory relaxation, the political costs could be severe.
What RFK Jr.’s HHS Changes Mean for Your Health
For individual Americans, the practical implications are immediate and concrete:
Vaccination decisions. The CDC’s childhood vaccine schedule may shift. Stay in close communication with your pediatrician, who can provide personalized guidance based on your child’s health profile and current evidence. The American Academy of Pediatrics continues to recommend the current vaccination schedule.
Mental health access. If you or someone you know depends on a federally-funded treatment program, investigate whether that program’s funding has been affected. The 988 Suicide & Crisis Lifeline (call or text 988) remains operational. State and local mental health resources may become increasingly important as federal funding shifts.
FDA-regulated products. Changes to FDA regulatory standards could affect the safety and efficacy of drugs, supplements, and food products over time. Maintain a relationship with a trusted healthcare provider who can help navigate changing recommendations.
Information hygiene. In a period of rapid policy change and conflicting claims, maintaining access to multiple credible information sources is critical. The CDC, NIH, WHO, and major medical journals continue to publish evidence-based guidance. Your personal physician remains your best source for individualized health decisions.
The most important thing anyone can do is stay informed, think critically about claims from all sources (government officials, health influencers, and media alike), and make health decisions based on the totality of evidence rather than any single authority’s perspective. Understanding the real science behind how viruses interact with our bodies provides a foundation for evaluating competing claims about vaccination and immunity.
Things I Know Nothing About is an AI-generated podcast exploring science, technology, and the unknown. New episodes weekly.
Frequently Asked Questions About RFK Jr. and Health Policy Changes
Has RFK Jr. officially changed CDC vaccine recommendations?
As of early 2026, no official directive has publicly reversed the CDC’s position that vaccines don’t cause autism. However, structural changes — including the reconstitution of the Advisory Committee on Immunization Practices (ACIP) with members more aligned with Kennedy’s views — suggest a gradual shift in how vaccine policy is shaped. Internal reports indicate pressure on CDC scientists to soften pro-vaccination language. The American Academy of Pediatrics continues to recommend the standard childhood vaccination schedule.
Are measles outbreaks getting worse in the United States?
Yes. After measles was declared eliminated in the U.S. in 2000, declining vaccination rates in some communities have allowed outbreaks to return. Measles is extremely contagious — one infected person can transmit the virus to 90% of unvaccinated contacts. Herd immunity requires 95% vaccination coverage, and several communities have fallen below this threshold. The CDC reported hundreds of cases across multiple states in 2025-2026.
What mental health programs are being cut under RFK Jr.?
Reports indicate cuts to SAMHSA (Substance Abuse and Mental Health Services Administration) grants that fund community mental health centers, crisis intervention services, substance abuse treatment programs, and the behavioral health workforce. These cuts affect frontline services for people with addiction, depression, anxiety, and suicidal ideation. The 988 Suicide & Crisis Lifeline remains operational, but local treatment capacity may be reduced in areas that depend on federal grant funding.
Is RFK Jr. changing what foods the FDA allows?
Kennedy has signaled interest in reviewing food additives, ultra-processed food regulation, and agricultural chemical approvals. Some of these changes — like reassessing additives approved decades ago under outdated safety standards — have broad support from health advocates. The specifics of FDA food regulatory changes are still emerging, and it remains unclear whether changes will be evidence-based reforms or ideologically driven policy shifts.